Nanoparticle‐Mediated Delivery of Anti‐PU.1 siRNA via Localized Intracisternal Administration Reduces Neuroinflammation
Advanced Materials · 2024-02 · 36 (8)
DOI: 10.1002/adma.202309225 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 08.12.2023. Verfasst von William T Ralvenius und 7 weiteren Autor:innen. Beteiligte Einrichtung: Picower Institute for Learning and Memory, Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, MA, 02139, U…. Hauptthemen laut MEDLINE: Alzheimer Disease, Nanoparticles. Die Arbeit wurde bisher 85-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Swiss National Science Foundation, Alzheimer's Association, Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung.
Abstract (Originalsprache)
Neuroinflammation is a hallmark of neurodegenerative disorders including Alzheimer's disease (AD). Microglia, the brain's immune cells, express many of the AD‐risk loci identified in genome wide association studies and present a promising target for anti‐inflammatory RNA therapeutics but are difficult to transfect with current methods. Here, several lipid nanoparticle (LNP) formulations are examined, and a lead candidate that supports efficient RNA delivery in cultures of human stem cell‐derived microglia‐like cells (iMGLs) and animal models of neuroinflammation is identified. The lead microglia LNP (MG‐LNP) formulation shows minimal toxicity and improves delivery efficiency to inflammatory iMGLs, suggesting a preference for delivery into activated microglia. Intraperitoneal injection of the MG‐LNP formulation generates widespread expression of the delivered reporter construct in all organs, whereas local intracisternal injection directly into the cerebrospinal fluid leads to preferential expression in the brain. It is shown that LNP‐mediated delivery of siRNA targeting the PU.1 transcription factor, a known AD‐risk locus, successfully reduces PU.1 levels in iMGLs and reduces neuroinflammation in mice injected with LPS and in CK‐p25 mice that mimic the chronic neuroinflammation seen in AD patients. The LNP formulation represents an effective RNA delivery vehicle when applied intrathecally and can be broadly utilized to test potential neuroinflammation‐directed gene therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Picower Institute for Learning and Memory, Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, MA, 02139, USA.
- Department of Chemistry, Massachusetts Institute of Technology, Cambridge, MA, 02139, USA.
- Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, 02139, USA.
- UNC Eshelman School of Pharmacy, Department of Pharmacoengineering and Molecular Pharmaceutics, University of North Carolina, Chapel Hill, NC, 27599, USA.
- Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA, 02139, USA.
- Broad Institute of MIT and Harvard, Cambridge, MA, 02139, USA.
ORCID-Profile: Owen S Fenton, Robert Langer
Förderung
- Swiss National Science Foundation
- Alzheimer's Association
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
- JPB Foundation
Zitieren
APA
Ralvenius, W. T., Andresen, J. L., Huston, M. M., Penney, J., Bonner, J. M., Fenton, O. S., Langer, R., & Tsai, L. H. (2024). Nanoparticle‐Mediated Delivery of Anti‐PU.1 siRNA via Localized Intracisternal Administration Reduces Neuroinflammation. Advanced Materials, 36(8). https://doi.org/10.1002/adma.202309225
Vancouver
Ralvenius WT, Andresen JL, Huston MM, Penney J, Bonner JM, Fenton OS, et al. Nanoparticle‐Mediated Delivery of Anti‐PU.1 siRNA via Localized Intracisternal Administration Reduces Neuroinflammation. Advanced Materials. 2024;36(8). doi:10.1002/adma.202309225
BibTeX
@article{Ralvenius2024,
author = {Ralvenius, William T and Andresen, Jason L and Huston, Margaret M and Penney, Jay and Bonner, Julia Maeve and Fenton, Owen S and Langer, Robert and Tsai, Li-Huei},
title = {Nanoparticle‐Mediated Delivery of Anti‐PU.1 siRNA via Localized Intracisternal Administration Reduces Neuroinflammation},
journal = {Advanced Materials},
year = {2024},
volume = {36},
number = {8},
doi = {10.1002/adma.202309225}
}
EUVIMED